In summary, AE2 was overexpressed in ovarian cancer samples, and up-regulated AE2 expression can activate the mTOR/p70S6K1 pathway, promoting ovarian cancer cell growth. This evidence concerns the gene SLC4A2 and ovarian carcinoma.